Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-25-002024
Filing Date
2025-01-24
Accepted
2025-01-24 16:15:08
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 form4a-01242025_040104.html 4/A  
1 form4a-01242025_040104.xml 4/A 5167
  Complete submission text file 0001415889-25-002024.txt   6535
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address
Regnante Keith (Reporting) CIK: 0001682068 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39264 | Film No.: 25554385